Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 05:30 ET | Source: Monaghan Medical Corporation

Back-to-School Season Brings Hidden Health Risk: New Portable Device Helps Families Navigate September's "Asthma Peak"

Monaghan Medical announces the nationwide availability of the AeroChamber2go® Valved Holding Chamber (VHC), a portable inhaler chamber and case.
September 24, 2025 08:30 ET | Source: Er-Kim Pharmaceuticals

Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases

Distribution agreement expands access of Nulibry and Zokinvy to 33 countries within CEE, the Mediterranean, and Eurasia
September 18, 2025 09:00 ET | Source: Nuwellis, Inc.

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No....
September 10, 2025 13:52 ET | Source: Bethany Children's Health Center

New Book, A Legacy of Hope, Traces Four Decades of Faith and Vision Behind Leading Pediatric Health Center

Bethany, Okla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- In their newly released book, A Legacy of Hope, longtime leaders and brother-sister duo Carol and Albert Gray chronicle the extraordinary...
September 08, 2025 15:07 ET | Source: Persephone Biosciences, Inc.

Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic

Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
August 06, 2025 07:00 ET | Source: Teva Pharmaceutical Industries Ltd

FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

FDA approves single-dose AJOVY® (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and adolescents aged 6-17 who weigh 45 kilograms or more, offering a...
July 28, 2025 08:30 ET | Source: Junior Patriots Corp

Smith Profits Offers Shriners Children's Hospital the Opportunity to Transform Young Patients into #1 Best Selling Authors Through Patriotic Book Series

Smith Profits, the Winter Garden, Florida-based business consulting and publishing company, announced a groundbreaking opportunity for Shriner's Hospitals.
July 25, 2025 07:00 ET | Source: Sobi, Inc.

Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in...
July 22, 2025 08:30 ET | Source: InStride Health

InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer

InStride Health names Don LeBlanc CCO and Joe Pietrzak CFO to help scale its proven pediatric anxiety and OCD care model nationwide.
July 22, 2025 06:00 ET | Source: Bunzl Canada Inc

25 ans d’espoir pour la recherche sur les tumeurs cérébrales pédiatriques

Les dons recueillis lors du tournoi de golf annuel de Bunzl Canada approchent les 2 M$ en 2025 BURLINGTON, Ontario, 22 juill. 2025 (GLOBE NEWSWIRE) -- Bunzl Canada a récemment tenu son 25e...